-+ 0.00%
-+ 0.00%
-+ 0.00%

Cybin names Executive Chairman Eric So interim CEO as Michael Cola steps down

PUBT·04/20/2026 12:03:09
Listen to the news
Cybin names Executive Chairman Eric So interim CEO as Michael Cola steps down
  • Cybin operating unit Helus Pharma removed Michael Cola as chief executive officer, effective immediately.
  • Co-founder Executive Chairman Eric So resumed role as interim CEO, effective immediately.
  • So previously served as interim CEO; he has led corporate strategy, development, and finance across start-up, growth-stage, and multinational businesses.
  • Board initiated search for a permanent CEO.
  • Management transition keeps focus on Phase 3 HLP003 APPROACH topline data expected in Q4.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cybin Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604200800PRIMZONEFULLFEED9692971) on April 20, 2026, and is solely responsible for the information contained therein.